uniQure Announces Dosing of First Patients in Europe Open-Label Trial of AMT-130katie8288Feb 7, 20220 min read
Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets
Comments